You just read:

Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases

News provided by

Skyhawk Therapeutics

06 May, 2019, 14:27 BST